Industry Overview - The U.S. cannabis sector is evolving with increasing legalization momentum and a focus on profitability and operational efficiency [1] - Multi-state operators are being closely monitored by investors for growth opportunities, while industry consolidation may lead to stronger long-term leaders [1] Trulieve Cannabis Corp. (TCNNF) - Trulieve is one of the largest U.S. cannabis operators with a dominant presence in Florida and a vertically integrated model controlling cultivation, processing, and retail distribution [2][3] - The company operates over 230 dispensaries nationwide, with Florida being its most profitable market, providing a competitive advantage in medical cannabis sales [3][5] - Trulieve reported approximately $1.2 billion in revenue, achieving strong gross margins compared to peers, indicating operational efficiency [6] - Despite a net loss, Trulieve's adjusted EBITDA remained strong, and it generated solid operating cash flow, maintaining a strong cash position for future expansion [8][9] Cresco Labs Inc. (CRLBF) - Cresco Labs focuses on branded products and wholesale distribution, operating retail dispensaries under the Sunnyside brand [9][10] - The company has a strong presence in key markets like Illinois and Pennsylvania, emphasizing large-scale production and distribution [10][11] - Cresco reported annual revenue in the hundreds of millions, reflecting a decline from previous levels due to broader sector pressures, and also reported a net loss [12][13] - The company is prioritizing profitability over rapid expansion, with cost reductions supporting future earnings growth [14] Verano Holdings Corp. (VRNOF) - Verano is a leading multi-state cannabis operator with a strong presence in limited-license states, which typically offer higher margins and less competition [14][15] - The company operates dispensaries under the Zen Leaf and MÜV brands and has focused on disciplined expansion while prioritizing profitability [17][19] - Verano has consistently reported strong annual sales and maintains healthy gross margins, although profitability remains a challenge due to pricing and regulatory costs [18][19] - The company is focused on reducing expenses and strengthening its balance sheet, positioning itself for long-term growth as the industry matures [19][20] Final Thoughts - The U.S. cannabis industry presents both risks and opportunities, with a need for selective stock choices [20] - Companies with strong balance sheets and market positions, such as Trulieve, Cresco, and Verano, are highlighted as key players [21]

Core Insights - Planet 13 Holdings Inc. reported its financial results for Q4 and the full year 2025, indicating a stabilization in revenue and a focus on operational improvements [1][2][3]. Financial Highlights - Q4 2025 - Q4 2025 revenue was $25.2 million, a decrease of 16.7% from $30.3 million in Q4 2024, attributed to the tourist environment in Las Vegas and competition in Florida [4][5]. - The net loss for Q4 2025 was $4.6 million, significantly improved from a net loss of $26.4 million in Q4 2024, which included an impairment of $18.9 million [5][6]. - Adjusted EBITDA loss for Q4 2025 was $0.3 million, compared to an adjusted EBITDA of $0.0 million in Q4 2024 [5][6]. Financial Highlights - Full Year 2025 - Total revenue for 2025 was $103.4 million, down 11.2% from $116.4 million in 2024, again due to the tourist environment and competition [6][8]. - Gross profit for 2025 was $39.9 million, representing a gross margin of 38.6%, down from 48.2% in 2024, primarily due to weaker flower quality and increased competition [6][8]. - The net loss for the full year 2025 was $63.9 million, compared to a net loss of $47.8 million in 2024, which included $29.8 million in non-cash impairment charges [6][8]. Operational Developments - The company has exited California, which was a persistent drag on performance, and is focusing on enhancing its competitive position in Florida with a new BHO lab [3][12]. - Planet 13 opened two new dispensaries in Florida in late 2025 and launched a new rewards program in early 2026 [12][16]. Balance Sheet Overview - As of December 31, 2025, cash and restricted cash totaled $15.6 million, down from $25.4 million in 2024 [11][22]. - Total assets decreased to $152.3 million from $206.7 million, while total liabilities increased to $101.2 million from $94.0 million [11][19].

Core Viewpoint - Tilray Brands has shown a 7% stock price increase over the past 12 months, but the overall performance remains poor, and the company is still not considered a worthwhile investment [1] Financial Performance - Tilray's revenue for Q2 of fiscal year 2026 reached a record $217.5 million, but this only represents a 3% year-over-year increase [2][3] - The net loss per share improved significantly to $0.41 from $0.99, and the company transitioned from a net debt of $3.8 million in Q1 2026 to a net cash position of $27.4 million [3] Market Conditions - The U.S. cannabis market presents a larger opportunity compared to Canada, but companies like Tilray may face significant challenges even if federal legalization occurs [4] - Legalization is expected to come with regulations that could hinder market growth, similar to the licensing regulations experienced in Canada [5] - Increased competition is anticipated post-legalization, which may undermine Tilray's existing product portfolio advantages [5]

Industry Overview - The cannabis industry has rapidly transformed into one of the fastest-growing sectors globally, with legal cannabis market sales reaching billions of dollars [1] - Projections indicate that the cannabis market will continue to experience double-digit growth, with estimates suggesting an annual growth rate of over 13% through the early 2030s [2] - A majority of Americans now have access to legal cannabis dispensaries, and the industry supports hundreds of thousands of jobs, indicating its transition from a niche product to a mainstream consumer category [3] Company Highlights - **Curaleaf Holdings, Inc.** reported a net revenue of $1,268.1 million for Q4 and full-year 2025, with international revenue increasing by 63% to $172.5 million compared to 2024 [10] - Curaleaf's gross profit was $631.0 million, resulting in a gross margin of 50%, and the company expanded its retail presence in Florida to 70 dispensaries, bringing the nationwide total to 159 [10] - **Green Thumb Industries Inc.** reported revenue of $311.1 million for Q4 2025, a 5.7% increase over the prior year, with a full-year revenue of $1.2 billion, reflecting a 3.4% increase [12]

Core Insights - WM Technology, Inc. reported fourth quarter revenue of $43.1 million and full year revenue of $174.7 million, reflecting challenges in the cannabis industry [1] - The company achieved consecutive quarters of adjusted EBITDA profitability and full year net income profitability [1] - Nick Rellas was appointed to the Board of Directors, bringing experience in consumer marketplaces [1] Financial Performance - Fourth quarter revenue decreased from $47.7 million in the prior year, attributed to pricing pressures in core markets [1] - Average monthly revenues per paying client fell to $2,804 from $3,041 year-over-year [1] - Average monthly paying clients decreased to 5,120 from 5,225 in the prior year [1] - The company reported a net loss of $5.0 million compared to a net income of $3.7 million in the prior year [1] - Adjusted EBITDA decreased to $10.4 million from $11.9 million in the prior year [1] Fiscal Year Overview - Full year revenue of $174.7 million decreased from $184.5 million in the prior year, driven by ongoing pricing pressures [1] - Average monthly revenues per paying client decreased to $2,805 from $3,029 year-over-year [1] - Average monthly paying clients increased to 5,190 from 5,077 in the prior year [1] - Net income decreased to $3.3 million from $12.2 million in the prior year [1] - Adjusted EBITDA for the year decreased to $39.8 million from $42.9 million [1] Balance Sheet and Cash Position - Total shares outstanding were 157.8 million as of December 31, 2025 [1] - Cash increased to $62.4 million as of December 31, 2025, compared to $52.0 million as of December 31, 2024 [1] Business Outlook - The company expects first quarter 2026 revenue to decline by mid- to high-single digit percentages sequentially from the fourth quarter [1]

Industry Overview - The cannabis sector is regaining investor interest after experiencing significant declines over the past two years, with federal cannabis reform discussions acting as a major catalyst for potential recovery [1][22] - Demand for cannabis is growing in both medical and adult-use markets, with several U.S. states expanding retail programs and increasing dispensary licenses, which supports long-term industry growth [2][22] Company Highlights Fluent Corp. (CNTMF) - Fluent Corp. is a vertically integrated cannabis company primarily focused on the U.S. medical cannabis market, with a strong presence in Florida, which is one of the largest medical cannabis markets in the U.S. [5][7] - The company operates approximately 30 dispensaries, mainly in Florida, and emphasizes quality products and strong patient relationships [6][7] - Fluent is investing in cultivation facilities and developing proprietary cannabis brands to differentiate itself in a crowded market, while also focusing on improving operational efficiency and reducing operating expenses [9][10] Glass House Brands Inc. (GLASF) - Glass House Brands is headquartered in California and operates cultivation, manufacturing, distribution, and retail operations, benefiting from California's status as the largest legal cannabis market in the U.S. [12][13] - The company focuses on greenhouse cultivation, which allows for more efficient production and lower costs, aiming to become one of the lowest-cost cannabis producers in the industry [13][15] - Glass House has reported improving operational performance, with revenue growth driven by increased cultivation output and a focus on reducing production costs [15][16] Verano Holdings Corp. (VRNOF) - Verano Holdings is a larger multi-state cannabis operator with operations across several major states, including Florida and Illinois, which are significant markets for cannabis [18][19] - The company operates approximately 158 dispensaries and maintains a vertically integrated model, allowing control over cultivation and production [18][19] - Verano generates significantly higher revenue than many cannabis penny stocks, with annual sales in the hundreds of millions, although it faces industry challenges such as federal prohibition and high tax burdens [20][21] Conclusion - The cannabis industry is dynamic, with regulatory developments and legalization efforts shaping its future, and as more states expand cannabis programs, demand for legal products is expected to rise [22][23] - Companies like Fluent Corp., Glass House Brands, and Verano Holdings are positioned within major cannabis markets, with their vertically integrated operations providing exposure to cultivation, manufacturing, and retail sales [23][24]

Industry Overview - The global cannabis industry is evolving with ongoing legalization across various regions, and Canadian cannabis producers play a significant role in this expansion [1][2] - Canada was the first major developed country to legalize recreational cannabis, leading to the establishment of early industry leaders with large cultivation facilities and recognizable brands [2] - Post-legalization, the Canadian cannabis market has faced challenges such as oversupply, price compression, and heavy regulations, prompting many companies to restructure operations [2] Market Dynamics - The industry is shifting towards efficiency and profitability, with companies focusing on cost reduction and margin improvement [3] - International medical cannabis markets, particularly in Europe, are becoming increasingly important, with countries like Germany expanding their medical cannabis programs [3] - The United States remains the largest potential cannabis market, and Canadian companies are preparing strategies for potential entry as federal reform discussions continue [4] Company Strategies - Diversification has become a key strategy for cannabis companies, with expansions into beverages, wellness products, and pharmaceutical research to generate additional revenue streams [5] - Canadian cannabis stocks are characterized by high volatility but still present significant upside potential for investors [5] Key Companies to Watch Tilray Brands Inc. - Tilray is one of the largest global cannabis companies, producing medical and recreational products and operating across cannabis, beverages, and wellness markets [6][10] - The company reported quarterly revenue exceeding $217 million in fiscal 2026, showing modest growth and improved operational efficiency [11] - Tilray's international sales, particularly in Europe, are growing, and the company is positioning itself for potential U.S. legalization through acquisitions and brand development [12][10] Canopy Growth Corporation - Canopy Growth is a major player in the cannabis industry, producing a wide range of products and maintaining strong brand recognition [13][14] - The company reported quarterly cannabis revenue of nearly $52 million, reflecting moderate year-over-year growth, while also focusing on restructuring to improve profitability [18] - Canopy has established a structure for potential U.S. market entry and holds interests in several American cannabis operators [16][17] Cronos Group Inc. - Cronos Group focuses on research and product innovation, emphasizing premium cannabis brands and cannabinoid development [20][24] - The company reported quarterly revenue of approximately $44.5 million, driven by higher sales of cannabis flower and international distribution [25] - Cronos benefits from significant financial backing from Altria, allowing for continued investment in research and development [24][26]

Industry Overview - The U.S. cannabis industry is expanding despite volatility, with ancillary companies playing a crucial role in the infrastructure by supplying equipment, nutrients, lighting, and hydroponic systems to cultivators [1][4] - Ancillary companies face fewer regulatory restrictions and can operate across state lines, allowing for faster scaling compared to plant-touching operators [2] - The demand for cultivation equipment is growing alongside the cannabis industry, as cultivators rely on hydroponic supplies and environmental controls for consistent crop production [2][4] Market Dynamics - The cannabis sector is experiencing price compression and oversupply in several states, but long-term growth prospects remain strong, with the U.S. cannabis market potentially exceeding $50 billion annually in the next decade [4] - Ancillary companies provide indirect exposure to the cannabis market, often avoiding heavy taxes and regulatory burdens, which can lead to more stable business models during downturns [5] Key Ancillary Companies - **GrowGeneration Corp. (GRWG)**: A leading hydroponic and gardening retailer serving cannabis cultivators, operating approximately 31 retail locations across major cultivation states. The company has focused on restructuring operations to improve profitability and has a strong balance sheet with potential for acquisitions [7][11][15] - **Hydrofarm Holdings Group Inc. (HYFM)**: A major supplier of hydroponic equipment, focusing on cultivation infrastructure for both cannabis and indoor agriculture. The company has faced revenue declines due to industry oversupply but is implementing cost reduction measures to stabilize margins [16][21][22] - **The Scotts Miracle-Gro Company (SMG)**: Known for lawn and garden products, its Hawthorne Gardening division supplies hydroponic equipment to cannabis growers. The company has a diversified business model, generating significant revenue from its core segment while maintaining strong relationships with cannabis cultivators [23][29][30]

Core Insights - The U.S. marijuana industry is rapidly expanding with more states legalizing cannabis for medical and adult use, creating investment opportunities in leading marijuana stocks [1] - The top three marijuana stocks to watch in March 2026 are Trulieve Cannabis Corp. (TCNNF), Green Thumb Industries Inc. (GTBIF), and Curaleaf Holdings Inc. (CURLF), each showcasing unique strengths within the cannabis ecosystem [1][10] Trulieve Cannabis Corp. (TCNNF) - Trulieve is a major vertically integrated cannabis operator with over 150 dispensaries across high-demand states like Florida, California, and Pennsylvania [2] - The company has shown resilience in financial performance, with revenue growth and improved gross margins, while net income returned to profitability for consecutive quarters [4][6] - Trulieve's diversified model attracts investors focused on scale and brand penetration, supported by proprietary product technologies and strategic partnerships [2][4] Green Thumb Industries Inc. (GTBIF) - Green Thumb is a leading cannabis consumer packaged goods company, focusing on branded products and proprietary formulations distributed through over 20 state markets [6] - The latest financial results indicate stabilized revenue growth, particularly from branded product segments, with improved gross margins and positive EBITDA [7] - The company emphasizes innovation and strategic partnerships, enhancing its brand recognition and operational stability [6][7] Curaleaf Holdings Inc. (CURLF) - Curaleaf operates over 200 dispensaries in major cannabis markets and combines retail operations with cultivation and ancillary business segments [8] - Recent financial reports show continued revenue growth driven by product demand and improved operating efficiency, with a focus on high-growth product categories [9] - The company's diversified revenue mix and technology-enabled solutions position it as a resilient player in the cannabis sector [8][9]

Financial Data and Key Metrics Changes - The company reported consolidated net revenue of $44.5 million for Q4 2025, a 47% increase year-over-year, driven by higher cannabis flower and extract sales [15] - Full-year 2025 net revenue grew organically by 25%, with record gross profit and Adjusted EBITDA achieved [5][18] - Adjusted gross profit for Q4 was $16.2 million, equating to a 36% margin, a 670 basis point improvement from the previous year [15] Business Line Data and Key Metrics Changes - In Canada, record quarterly net revenue was up 42% year-over-year, with significant contributions from flower, vapes, and edibles [5] - Spinach became the number 2 overall vape brand in Canada, achieving number 1 market share in vape cartridges [6][9] - In edibles, Spinach maintained a market share approaching 22%, with strong growth driven by new product launches [8] Market Data and Key Metrics Changes - In Israel, net revenue grew 52% year-over-year, marking the 8th consecutive quarter of record net revenue for the company in that market [10] - Internationally, net revenue increased by 68% year-over-year, led by growth in Germany [10] - The company announced plans to acquire CanAdelaar, the largest operator in the Netherlands' legal adult-use cannabis program, for approximately $67.5 million [11] Company Strategy and Development Direction - The company aims to leverage its strong balance sheet and self-sustaining business model to continue its share repurchase program while exploring M&A opportunities [19] - The acquisition of CanAdelaar is seen as a strategic move to establish a foothold in the Netherlands, a key market for adult-use cannabis [20] - The focus remains on delivering sustainable top-line growth and maintaining disciplined cost management as the company scales globally [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operating leverage of the business as production stabilizes and scale efficiencies are realized [16] - The company anticipates continued momentum in 2026, driven by increased production capacity and growth in branded products [20] - Management highlighted the importance of innovation, particularly in product categories like vapes and edibles, to maintain competitive advantage [7][44] Other Important Information - The company ended Q4 2025 with $832 million in cash equivalents and short-term investments, allowing for continued investment in growth and innovation [17] - Adjusted EBITDA for Q4 was $0.5 million, an improvement of $7.7 million year-over-year, despite being lower than the first three quarters of 2025 due to gross margin pressures [16] Q&A Session Summary Question: Product allocation from GrowCo capacity - Management indicated that decisions on product allocation balance market demand and margin considerations, with expectations for more consistent supply in 2026 [23][24] Question: Improving gross margins - Management noted that Q4 faced production quality mix challenges and one-time expenses, but expects margins to stabilize around 43% for the full year 2025 [25][29] Question: Revenue timing shifts - Management acknowledged some timing shifts in international markets contributing to revenue beats, but emphasized overall business growth [34] Question: Domestic market drivers - Management attributed the 40% year-over-year growth in Canada to increased supply, allowing the company to meet existing demand [40] Question: Future capital deployment - Management remains committed to the share buyback program while exploring international opportunities and potential new products [41] Question: Innovation trends - Management highlighted ongoing innovation in genetics, edibles, and vapes, with particular excitement around the PUFFERZ product launch [43][44] Question: Strategic focus on the Netherlands over Germany - Management explained that the Netherlands offers a unique opportunity to enter the adult-use market directly, while Germany presents regulatory uncertainties [49][50] Question: Downstream opportunities - Management prefers to be a customer rather than an owner of downstream assets unless long-term stability can be assured [52] Question: Lessons from past acquisition options - Management emphasized the importance of regulatory timing and the need for a disciplined approach to acquisitions in the U.S. market [59][60]